Wall Street Analysts Predict a 131.33% Upside in Oric Pharmaceuticals (ORIC): Here's What You Should Know

Shares of Oric Pharmaceuticals, Inc. (ORIC) have gained 44.1% over the past four weeks to close the last trading session at $8.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.90 indicates a potential upside of 131.3%.The average comprises 10 short-term price targets ranging from a low of $12 to a high of $25, with a standard deviation of $4.04. While the lowest estimate ...